Close Menu
    Facebook X (Twitter) Instagram
    ScoopSquare24
    • Home
    • News
    • AI
    • Crypto
    • Finance
    • Stocks
    Facebook X (Twitter) Instagram
    ScoopSquare24
    Home»News»Stocks»Palantir (PLTR) Shares Tumble 6% After Burry Warns Anthropic Is Dominating AI Market
    Stocks

    Palantir (PLTR) Shares Tumble 6% After Burry Warns Anthropic Is Dominating AI Market

    Oli DaleBy Oli DaleApril 9, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Key Takeaways

    • PLTR shares declined approximately 6% following Michael Burry’s assertion that the stock represents a possible “bubble”
    • Burry maintains Anthropic is capturing Palantir’s market position, highlighting ARR expansion from $9B to $30B
    • The company’s forward P/E ratio stands at roughly 115x, significantly exceeding the sector median of 21x
    • Wall Street opinions diverge: Rosenblatt maintains a $200 Buy rating; Benchmark expresses valuation reservations
    • Overall Street sentiment registers as Moderate Buy, featuring a consensus price target of $194.61

    The investor who achieved notoriety through “The Big Short,” Michael Burry, targeted Palantir Wednesday via a post on X, characterizing the equity as a potential market bubble while asserting that Anthropic has gained the upper hand in securing enterprise artificial intelligence contracts.

    His commentary triggered a roughly 6% decline in PLTR throughout the trading day. Shares subsequently recovered slightly to approximately $141.18 during extended-hours activity as purchasing interest emerged.


    PLTR Stock Card
    Palantir Technologies Inc., PLTR

    Burry had previously revealed a short stake in Palantir earlier in the year. His most recent statements advance his position further — contending that the competitive environment has fundamentally transformed.

    “Anthropic is eating Palantir’s lunch,” Burry stated. “That massive boost from $9B to $30B ARR at Anthropic is because Anthropic offers the easier, cheaper, intuitive solution for businesses.”

    He substantiated his argument using information from Ramp, a financial operations platform, referencing a March 2026 examination conducted by economist Ara Kharazian. The research indicated that approximately one in four companies utilizing Ramp currently subscribes to Anthropic — a sharp increase from one in 25 twelve months prior.

    Burry further highlighted that 73% of fresh enterprise AI expenditures are flowing toward Anthropic, while characterizing the AI sector as demonstrating zero-sum characteristics, with OpenAI experiencing its steepest monthly contraction ever recorded.

    Valuation Debate Continues

    With a forward P/E multiple hovering around 115x, Palantir commands a valuation substantially above its sector’s median of 21x and dwarfs comparable large-capitalization AI competitors. This valuation premium has consistently fueled bearish arguments.

    Benchmark analyst Yi Fu Lee maintains a measured stance, preserving a Hold recommendation. His perspective suggests the shares are priced assuming flawless operational performance, leaving vulnerability to any deceleration in expansion.

    Rosenblatt’s John McPeake offers a contrasting viewpoint. He reaffirmed a Buy designation alongside a $200 valuation target, highlighting forthcoming drivers including the “Golden Dome” missile defense initiative. His analysis suggests Palantir’s participation in this contract may deliver billions in top-line revenue extending through 2028.

    BofA analyst Mariana Perez similarly upholds a Buy stance, characterizing the downturn as a temporary response to media narratives. Her thesis emphasizes Palantir’s entrenchment within mission-critical government data systems as a sustainable competitive moat.

    Analyst Sentiment Overview

    Current Wall Street consensus registers as a Moderate Buy, comprising 14 Buy recommendations, 5 Hold ratings, and 2 Sell opinions.

    The mean price objective following recent volatility stands at $194.61, suggesting approximately 38% appreciation potential from Wednesday’s closing level.

    Palantir delivered 70% revenue expansion in its latest quarterly report, a metric optimists cite as confirmation that underlying business fundamentals remain robust despite ongoing valuation controversy.

    Burry isn’t the sole voice expressing caution. Short-seller Andrew Left unveiled a short position in Palantir last September, simultaneously identifying Databricks as a superior investment alternative.

    Anthropicremains privately held, preventing investors from establishing direct positions aligned with Burry’s investment thesis — however, the downward force on PLTR has materialized tangibly.

    The Maven Smart System achieving official designation represents among the most tangible immediate-term catalysts supporting the stock.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Oli Dale
    • Website

    Related Posts

    Circle Internet (CRCL) Hit with Class Action Lawsuit Over $280M Drift Protocol Breach

    April 17, 2026

    JPMorgan Analysts Say CLARITY Act Could Pass Before Midterm Elections

    April 17, 2026

    Tom Lee Predicts Further Gains After April 2026 Market Records

    April 17, 2026
    Leave A Reply Cancel Reply

    Breaking News
    Blockonomi

    Crypto News Just Turned Bullish: Coinbase CEO Brian Armstrong Calls a $60,000 Bitcoin Bottom While DOGE Holders Move to Pepeto

    Blockonomi
    Jun 16, 2026 9:27 PM
    Parameter

    CervoMed (CRVO) Stock Soars 32% on $3 Million Director Purchase

    Parameter
    Jun 16, 2026 8:27 PM
    Blockonomi

    CervoMed (CRVO) Surges 32% as Director Purchases $3 Million in Shares

    Blockonomi
    Jun 16, 2026 8:24 PM
    Moneycheck

    CervoMed (CRVO) Surges 32% Following Director’s $3 Million Stock Purchase

    Moneycheck
    Jun 16, 2026 8:24 PM
    Parameter

    Moderna (MRNA) Stock Surges 9% Following Positive FDA Assessment of mRNA Flu Vaccine

    Parameter
    Jun 16, 2026 8:20 PM
    Blockonomi

    Moderna (MRNA) Stock Surges 9% Following Positive FDA Review of mRNA Flu Vaccine

    Blockonomi
    Jun 16, 2026 8:17 PM
    Moneycheck

    Moderna (MRNA) Stock Surges 9% After FDA Gives Positive Signal on mRNA Flu Vaccine

    Moneycheck
    Jun 16, 2026 8:17 PM
    Coincentral

    CervoMed (CRVO) Stock Jumps 32% After Director Buys $3M – Time to Buy?

    Coincentral
    Jun 16, 2026 8:14 PM
    Parameter

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade from Underperform

    Parameter
    Jun 16, 2026 8:13 PM
    Blockonomi

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade to Peer Perform

    Blockonomi
    Jun 16, 2026 8:10 PM
    Moneycheck

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade to Peer Perform

    Moneycheck
    Jun 16, 2026 8:10 PM
    Coincentral

    Moderna (MRNA) Stock Jumps 9% as FDA Clears Key Hurdle for mRNA Flu Shot

    Coincentral
    Jun 16, 2026 8:06 PM
    Coincentral

    Palantir (PLTR) Stock Falls 2% Even After Getting a Wall Street Upgrade

    Coincentral
    Jun 16, 2026 8:01 PM
    Blockonomi

    Anchorage Digital Unlocks New SWEEP Infrastructure for Institutions

    Blockonomi
    Jun 16, 2026 7:16 PM
    Parameter

    Alphabet (GOOG) Stock: Rises as Google Expands Android 17 Parental Controls

    Parameter
    Jun 16, 2026 7:13 PM
    Facebook X (Twitter) Instagram Pinterest
    ScoopSquare24

    Copyright © 2013 - 2026 Kooc Media Ltd. All rights reserved. Registered Company No.05695741
    Our Sites: FlowPresets / GardenBeast / GolfMonster / Blockonomi / Money Check / CoinCentral / Parameter / Circlo / Computing.net

    Type above and press Enter to search. Press Esc to cancel.